Patents by Inventor Daniela Cocconi

Daniela Cocconi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
    Publication number: 20230364015
    Abstract: Carrier particles for dry powder formulations for inhalation having reduced electrostatic charges are prepared.
    Type: Application
    Filed: July 17, 2023
    Publication date: November 16, 2023
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Daniela COCCONI, Rossella Musa
  • Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 10946029
    Abstract: Compositions comprising a corticosteroid and a beta-adrenergic are useful for treating inflammatory or obstructive airways diseases.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: March 16, 2021
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
    Publication number: 20190216731
    Abstract: Carrier particles for dry powder formulations for inhalation having reduced electrostatic charges are prepared.
    Type: Application
    Filed: March 21, 2019
    Publication date: July 18, 2019
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Daniela Cocconi, Rossella Musa
  • DRY POWDER FORMULATION COMPRISING A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20180296573
    Abstract: Compositions comprising a corticosteroid and a beta-adrenergic are useful for treating inflammatory or obstructive airways diseases.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa MONARI, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 10028964
    Abstract: The invention relates to a dry powder formulation comprising corticosteroid and a beta2-adrenergic drug in combination, its process preparation, and therapeutic uses thereof.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: July 24, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20180133161
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: January 12, 2018
    Publication date: May 17, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Massimiliano DagIi ALBERI, Andrea BUSCA, Francesca SCHIARETTI
  • PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATION
    Publication number: 20160354314
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Application
    Filed: August 19, 2016
    Publication date: December 8, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Rossella MUSA, Daniela COCCONI, Alain CHAMAYOU, Laurence GALET
  • Process for preparing carrier particles for dry powders for inhalation
    Patent number: 9445999
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: September 20, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Alain Chamayou, Laurence Galet
  • Dry powder formulation comprising a phosphodiesterase inhibitor
    Patent number: 9308200
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: April 12, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Francesca Schiaretti, Roberto Bilzi
  • DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20150342936
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: August 7, 2015
    Publication date: December 3, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Francesca Schiaretti, Roberto Bilzi
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20150320691
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Massimiliano Dagli ALBERI, Andrea BUSCA, Francesca SCHIARETTI
  • Dry powder formulation comprising a phosphodiesterase inhibitor
    Patent number: 9132121
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: September 15, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Francesca Schiaretti, Roberto Bilzi
  • PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATION
    Publication number: 20150202159
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Application
    Filed: January 28, 2015
    Publication date: July 23, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Rossella MUSA, Daniela COCCONI, Alain CHAMAYOU, Laurence GALET
  • DRY POWDER FORMULATION COMPRISING A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20150164915
    Abstract: The invention relates to a dry powder formulation comprising corticosteroid and a beta2-adrenergic drug in combination, its process preparation, and therapeutic uses thereof.
    Type: Application
    Filed: January 23, 2013
    Publication date: June 18, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • Process for preparing carrier particles for dry powders for inhalation
    Patent number: 8974831
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: March 10, 2015
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Alain Chamayou, Laurence Galet
  • Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 8778402
    Abstract: Dry powder formulations comprising a corticosteroid and a beta2-adrenergic drug in combination are useful for the prevention and/or treatment of inflammatory or obstructive airways diseases.
    Type: Grant
    Filed: January 24, 2013
    Date of Patent: July 15, 2014
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • Micronized particles of low-dosage strength active agents for powder formulations for inhalation
    Patent number: 8512753
    Abstract: Micronized particles of a low-dosage strength active ingredient, to be used in dry powder formulations for inhalation, with particular properties can easily and homogenously disperse in a dry powder formulation to be administered by means of a dry powder inhaler device.
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: August 20, 2013
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Silvia Catinella
  • Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
    Patent number: 8153104
    Abstract: The invention provides a formulation to be administered as dry powder for inhalation suitable for efficacious delivery of low-dosage strength active ingredients to the low respiratory tract of patient. In particular, the invention provides a formulation comprising microparticles constituted of microparticles of a low-dosage strength active ingredient and microparticles of an excipient wherein the MMD of the microparticles is comprised between 2 and 15 micron, at least 10% of the microparticles has a mass diameter (MD) higher than 0.5 micron, and the process of preparation thereof.
    Type: Grant
    Filed: March 16, 2005
    Date of Patent: April 10, 2012
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Roberto Bilzi, Angela Armanni, Roberto Rastelli, Daniela Cocconi, Rosella Musa
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20120082727
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: September 22, 2011
    Publication date: April 5, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Massimiliano Dagli Alberi, Andrea Busca, Francesca Schiaretti
  • DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20120031403
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 9, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Francesca Schiaretti, Roberto Bilzi